<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title> &#187; Drug Delivery</title>
	<atom:link href="http://pharmaexecnews.com/category/pharmaceuticals/drug-delivery/feed/" rel="self" type="application/rss+xml" />
	<link>http://pharmaexecnews.com</link>
	<description></description>
	<lastBuildDate>Fri, 29 Apr 2011 14:00:12 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.4</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Catalent Adds Fast-Dissolve Tech to Oral Dose Arsenal</title>
		<link>http://pharmaexecnews.com/biotechnology/catalent-adds-fastdissolve-tech-oral-dose-arsenal/</link>
		<comments>http://pharmaexecnews.com/biotechnology/catalent-adds-fastdissolve-tech-oral-dose-arsenal/#comments</comments>
		<pubDate>Wed, 02 Mar 2011 08:00:20 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Companies]]></category>
		<category><![CDATA[Drug Delivery]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11208</guid>
		<description><![CDATA[Adding to its store of technology weapons, Catalent Pharma can now offer fast-dissolve tablet technology to clients. It obtained the development rights to Lyopan from Pantec. The lyophilized tablets are used for such OTC products as allergy treatments and travel medications, says Catalent. The technology uses less water than other oral dose technologies, reducing not [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/catalent-adds-fastdissolve-tech-oral-dose-arsenal/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Delivering a Potent Cancer Drug with Nanoparticles can Lessen Side Effects</title>
		<link>http://pharmaexecnews.com/biotechnology/delivering-potent-cancer-drug-nanoparticles-lessen-side-effects/</link>
		<comments>http://pharmaexecnews.com/biotechnology/delivering-potent-cancer-drug-nanoparticles-lessen-side-effects/#comments</comments>
		<pubDate>Wed, 23 Feb 2011 08:00:04 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Drug Delivery]]></category>
		<category><![CDATA[Nanotechnology]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[cancer therapies]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11189</guid>
		<description><![CDATA[Researchers at MIT and Brigham and Women&#8217;s Hospital have shown that they can deliver the cancer drug cisplatin much more effectively and safely in a form that has been encapsulated in a nanoparticle targeted to prostate tumor cells and is activated once it reaches its target.  Using the new particles, the researchers were able to [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/delivering-potent-cancer-drug-nanoparticles-lessen-side-effects/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Nasal Delivery of Anti-vomiting Drug Patent Won</title>
		<link>http://pharmaexecnews.com/biotechnology/nasal-delivery-antivomiting-drug-patent-won/</link>
		<comments>http://pharmaexecnews.com/biotechnology/nasal-delivery-antivomiting-drug-patent-won/#comments</comments>
		<pubDate>Thu, 27 Jan 2011 08:00:39 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Devices and Technology]]></category>
		<category><![CDATA[Drug Delivery]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Market News]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[cancer therapies]]></category>
		<category><![CDATA[pharmaceutical companies]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11111</guid>
		<description><![CDATA[There are many reasons cancer patients can dread chemotherapy. It might kill their cancer, but those who go through it often wonder if the cure is just as bad as the disease. Among the uncomfortable symptoms is chemotherapy-induced vomiting. Ahmedabad, India-based Lincoln Pharmaceuticals has been granted a patent for its nasal drug delivery system (NDDS) [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/nasal-delivery-antivomiting-drug-patent-won/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Inhaled Insulin Closer to Reality</title>
		<link>http://pharmaexecnews.com/biotechnology/inhaled-insulin-closer-reality/</link>
		<comments>http://pharmaexecnews.com/biotechnology/inhaled-insulin-closer-reality/#comments</comments>
		<pubDate>Thu, 20 Jan 2011 08:00:37 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Devices and Technology]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Drug Delivery]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[pharmaceutical companies]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11090</guid>
		<description><![CDATA[A Holy Grail in the drug-delivery business is the quest for a needle-free way for diabetics to take their insulin. Galway, Ireland-based Aerogen and San Francisco-based Dance Pharmaceuticals believe they have found the secret passageway&#8211;through the nose. And they&#8217;ve announced a drug-delivery partnership to develop an inhaled-insulin device.

The device will administer Dance&#8217;s insulin product using [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/inhaled-insulin-closer-reality/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pfizer Bungles Tax-Fueled Champix Surge</title>
		<link>http://pharmaexecnews.com/biotechnology/pfizer-bungles-taxfueled-champix-surge/</link>
		<comments>http://pharmaexecnews.com/biotechnology/pfizer-bungles-taxfueled-champix-surge/#comments</comments>
		<pubDate>Mon, 17 Jan 2011 08:00:37 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Drug Delivery]]></category>
		<category><![CDATA[Financial]]></category>
		<category><![CDATA[General News]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[pharmaceutical companies]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11078</guid>
		<description><![CDATA[A new cigarette tax and a stop-smoking drug were a match made in Japan, and it might have been heaven if Pfizer ($PFE) hadn&#8217;t fumbled. The drugmaker, which sells its Chantix remedy as Champix in Japan, knew the higher tax was coming, advertised its drug heavily, and then failed to make enough to satisfy demand.

As [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/pfizer-bungles-taxfueled-champix-surge/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Footstar  to acquire CPEX&#8217;s Drug-Delivery Technology</title>
		<link>http://pharmaexecnews.com/pharmaceuticals/footstar-acquire-cpexs-drugdelivery-technology/</link>
		<comments>http://pharmaexecnews.com/pharmaceuticals/footstar-acquire-cpexs-drugdelivery-technology/#comments</comments>
		<pubDate>Fri, 14 Jan 2011 08:00:29 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Deals and Mergers]]></category>
		<category><![CDATA[Devices and Technology]]></category>
		<category><![CDATA[Drug Delivery]]></category>
		<category><![CDATA[Financial]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[pharmaceutical companies]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11074</guid>
		<description><![CDATA[A unit of Footstar Corp., a holding company, has agreed to acquire CPEX Pharmaceuticals for $76.6 million in cash. The bid is worth $27.25 a share&#8211;more than twice what it was a year ago as back-to-back quarterly profits helped fuel investor interest. CPEX focuses on what it calls a &#8220;drug delivery platform technology.&#8221; Platform, of [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/pharmaceuticals/footstar-acquire-cpexs-drugdelivery-technology/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Gold-plated Liposomes an Anti-Cancer Stocking Stuffer</title>
		<link>http://pharmaexecnews.com/biotechnology/goldplated-liposomes-anticancer-stocking-stuffer/</link>
		<comments>http://pharmaexecnews.com/biotechnology/goldplated-liposomes-anticancer-stocking-stuffer/#comments</comments>
		<pubDate>Thu, 30 Dec 2010 08:00:17 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Drug Delivery]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[Medical Patents]]></category>
		<category><![CDATA[Medical Research]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[c reactive protein]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[cancer therapies]]></category>
		<category><![CDATA[nanobiotechnology]]></category>
		<category><![CDATA[nanotechnology]]></category>
		<category><![CDATA[Nanotechnology - Revolutionizing R&D to Develop Smarter Therapeutics and Diagnostics]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11018</guid>
		<description><![CDATA[No, gold-plated liposomes are not a luxury gift that you&#8217;d find in your Christmas stocking, but they could someday give cancer patients the gift of life by selectively knocking out cancer cells while leaving healthy ones alone. This holiday gift comes courtesy of Marek Romanowski, an associate professor of biomedical engineering in the University of [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/goldplated-liposomes-anticancer-stocking-stuffer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA Loses Battle in War Against e-cigarettes</title>
		<link>http://pharmaexecnews.com/biotechnology/fda-loses-battle-war-ecigarettes/</link>
		<comments>http://pharmaexecnews.com/biotechnology/fda-loses-battle-war-ecigarettes/#comments</comments>
		<pubDate>Wed, 15 Dec 2010 08:00:54 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Devices and Technology]]></category>
		<category><![CDATA[Drug Delivery]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[Industry News Alerts]]></category>
		<category><![CDATA[Market News]]></category>
		<category><![CDATA[MedWatch Safety Alerts]]></category>
		<category><![CDATA[Regulatory]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=10974</guid>
		<description><![CDATA[Electronic cigarettes are nicotine-delivery devices that include a heating element that vaporizes chemicals in replaceable plastic cartridges. Researchers at the University of California, Riverside recently evaluated five e-cigarette brands and, finding design flaws, lack of adequate labeling, and several concerns about quality control and health issues, concluded that e-cigarettes are potentially harmful and urged regulators [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/fda-loses-battle-war-ecigarettes/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Cloaking Device Boldly Delivers Toxins to Tumor</title>
		<link>http://pharmaexecnews.com/biotechnology/bioinformatics/cloaking-device-boldly-delivers-toxins-tumor/</link>
		<comments>http://pharmaexecnews.com/biotechnology/bioinformatics/cloaking-device-boldly-delivers-toxins-tumor/#comments</comments>
		<pubDate>Wed, 13 Oct 2010 08:00:44 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Devices and Technology]]></category>
		<category><![CDATA[Drug Delivery]]></category>
		<category><![CDATA[Financial]]></category>
		<category><![CDATA[General News]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[Industry News Alerts]]></category>
		<category><![CDATA[Market News]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Research Reports]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Strategic Alliances in World Pharma and Biotech Markets]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=10787</guid>
		<description><![CDATA[Yes, Star Trek geeks can rejoice. There is now a &#8220;cloaking device&#8221; for drug delivery. At least, that&#8217;s how researchers at the University  of Massachusetts Amherst describe what they&#8217;re doing. In the current issue of Nature Chemistry, Vincent Rotello says he and his team can deliver a dormant toxin into a specific site such [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/bioinformatics/cloaking-device-boldly-delivers-toxins-tumor/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>GSK, Theravance report promising PhII data for Advair successor</title>
		<link>http://pharmaexecnews.com/pharmaceuticals/gsk-theravance-report-promising-phii-data-advair-successor/</link>
		<comments>http://pharmaexecnews.com/pharmaceuticals/gsk-theravance-report-promising-phii-data-advair-successor/#comments</comments>
		<pubDate>Fri, 01 Oct 2010 08:00:53 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[Companies]]></category>
		<category><![CDATA[Drug Delivery]]></category>
		<category><![CDATA[Drug Trials]]></category>
		<category><![CDATA[Financial]]></category>
		<category><![CDATA[Industry News Alerts]]></category>
		<category><![CDATA[Market News]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[New Drugs]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[Regulatory]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[generic drugs]]></category>
		<category><![CDATA[pharmaceutical companies]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=10754</guid>
		<description><![CDATA[GlaxoSmithKline and partner Theravance (THRX) say that their planned successor for the blockbuster Advair turned in a positive performance in a mid-stage study involving 60 people with COPD. Significantly, the new drug&#8211;dubbed Relovair&#8211;outperformed Advair on a key measure that gauges lung function. And that bodes well for the therapy, which is now in late-stage trials [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/pharmaceuticals/gsk-theravance-report-promising-phii-data-advair-successor/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

